Delayed hypercoagulability after a single dose of adriamycin to normal rats

Andreina Poggi, Laura Kornblihtt, Federica Delaini, Tina Colombo, Luciana Mussoni, Ine Reyers, Marie Benedetta Donati

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Single doses of Adriamycin to normal rats, at levels active as an anticancer agent in this animal species, did not induce any acute changes in haemostatic parameters such as blood platelets, fibrinogen level or spontaneous fibrinolytic activity, as long as plasma drug levels were measurable. Starting from 2 weeks after a single dose, however, a hypercoagulable state developed, characterized by increased fibrinogen and factor VIII levels, short activated partial thromboplastin time, low antithrombin levels and depressed fibrinolytic activity. These changes were dose-related and lasted at least 5 weeks after treatment. An increased tendency to occlusive arterial thrombosis was also observed in treated rats. The pathogenesis of this disorder could be related to tissue damage induced by the drug, possibly nephrotoxicity.

Original languageEnglish
Pages (from-to)639-650
Number of pages12
JournalThrombosis Research
Volume16
Issue number5-6
DOIs
Publication statusPublished - 1979

Fingerprint

Thrombophilia
Doxorubicin
Fibrinogen
Antithrombins
Partial Thromboplastin Time
Factor VIII
Hemostatics
Pharmaceutical Preparations
Antineoplastic Agents
Thrombosis
Blood Platelets

Keywords

  • Adriamycin
  • Hypercoagulability
  • Nephrotic syndrome
  • Thrombotic tendency

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Hematology

Cite this

Poggi, A., Kornblihtt, L., Delaini, F., Colombo, T., Mussoni, L., Reyers, I., & Donati, M. B. (1979). Delayed hypercoagulability after a single dose of adriamycin to normal rats. Thrombosis Research, 16(5-6), 639-650. https://doi.org/10.1016/0049-3848(79)90208-1

Delayed hypercoagulability after a single dose of adriamycin to normal rats. / Poggi, Andreina; Kornblihtt, Laura; Delaini, Federica; Colombo, Tina; Mussoni, Luciana; Reyers, Ine; Donati, Marie Benedetta.

In: Thrombosis Research, Vol. 16, No. 5-6, 1979, p. 639-650.

Research output: Contribution to journalArticle

Poggi, A, Kornblihtt, L, Delaini, F, Colombo, T, Mussoni, L, Reyers, I & Donati, MB 1979, 'Delayed hypercoagulability after a single dose of adriamycin to normal rats', Thrombosis Research, vol. 16, no. 5-6, pp. 639-650. https://doi.org/10.1016/0049-3848(79)90208-1
Poggi A, Kornblihtt L, Delaini F, Colombo T, Mussoni L, Reyers I et al. Delayed hypercoagulability after a single dose of adriamycin to normal rats. Thrombosis Research. 1979;16(5-6):639-650. https://doi.org/10.1016/0049-3848(79)90208-1
Poggi, Andreina ; Kornblihtt, Laura ; Delaini, Federica ; Colombo, Tina ; Mussoni, Luciana ; Reyers, Ine ; Donati, Marie Benedetta. / Delayed hypercoagulability after a single dose of adriamycin to normal rats. In: Thrombosis Research. 1979 ; Vol. 16, No. 5-6. pp. 639-650.
@article{45ecd1c30882403a82f91986d14b9667,
title = "Delayed hypercoagulability after a single dose of adriamycin to normal rats",
abstract = "Single doses of Adriamycin to normal rats, at levels active as an anticancer agent in this animal species, did not induce any acute changes in haemostatic parameters such as blood platelets, fibrinogen level or spontaneous fibrinolytic activity, as long as plasma drug levels were measurable. Starting from 2 weeks after a single dose, however, a hypercoagulable state developed, characterized by increased fibrinogen and factor VIII levels, short activated partial thromboplastin time, low antithrombin levels and depressed fibrinolytic activity. These changes were dose-related and lasted at least 5 weeks after treatment. An increased tendency to occlusive arterial thrombosis was also observed in treated rats. The pathogenesis of this disorder could be related to tissue damage induced by the drug, possibly nephrotoxicity.",
keywords = "Adriamycin, Hypercoagulability, Nephrotic syndrome, Thrombotic tendency",
author = "Andreina Poggi and Laura Kornblihtt and Federica Delaini and Tina Colombo and Luciana Mussoni and Ine Reyers and Donati, {Marie Benedetta}",
year = "1979",
doi = "10.1016/0049-3848(79)90208-1",
language = "English",
volume = "16",
pages = "639--650",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "5-6",

}

TY - JOUR

T1 - Delayed hypercoagulability after a single dose of adriamycin to normal rats

AU - Poggi, Andreina

AU - Kornblihtt, Laura

AU - Delaini, Federica

AU - Colombo, Tina

AU - Mussoni, Luciana

AU - Reyers, Ine

AU - Donati, Marie Benedetta

PY - 1979

Y1 - 1979

N2 - Single doses of Adriamycin to normal rats, at levels active as an anticancer agent in this animal species, did not induce any acute changes in haemostatic parameters such as blood platelets, fibrinogen level or spontaneous fibrinolytic activity, as long as plasma drug levels were measurable. Starting from 2 weeks after a single dose, however, a hypercoagulable state developed, characterized by increased fibrinogen and factor VIII levels, short activated partial thromboplastin time, low antithrombin levels and depressed fibrinolytic activity. These changes were dose-related and lasted at least 5 weeks after treatment. An increased tendency to occlusive arterial thrombosis was also observed in treated rats. The pathogenesis of this disorder could be related to tissue damage induced by the drug, possibly nephrotoxicity.

AB - Single doses of Adriamycin to normal rats, at levels active as an anticancer agent in this animal species, did not induce any acute changes in haemostatic parameters such as blood platelets, fibrinogen level or spontaneous fibrinolytic activity, as long as plasma drug levels were measurable. Starting from 2 weeks after a single dose, however, a hypercoagulable state developed, characterized by increased fibrinogen and factor VIII levels, short activated partial thromboplastin time, low antithrombin levels and depressed fibrinolytic activity. These changes were dose-related and lasted at least 5 weeks after treatment. An increased tendency to occlusive arterial thrombosis was also observed in treated rats. The pathogenesis of this disorder could be related to tissue damage induced by the drug, possibly nephrotoxicity.

KW - Adriamycin

KW - Hypercoagulability

KW - Nephrotic syndrome

KW - Thrombotic tendency

UR - http://www.scopus.com/inward/record.url?scp=0018691630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018691630&partnerID=8YFLogxK

U2 - 10.1016/0049-3848(79)90208-1

DO - 10.1016/0049-3848(79)90208-1

M3 - Article

C2 - 524314

AN - SCOPUS:0018691630

VL - 16

SP - 639

EP - 650

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 5-6

ER -